false
English
Catalog
2023 World Conference on Lung Cancer (Posters)
EP07.03. Robotic Lung Cancer Program: Initial Expe ...
EP07.03. Robotic Lung Cancer Program: Initial Experience and Results - PDF(Slides)
Back to course
Pdf Summary
The study reported the initial experience and results of a robotic lung cancer program. Minimally invasive surgery is the current standard for lung cancer surgery, and robotic surgery is becoming increasingly preferred due to better viewing, ergonomics, and more accurate resections. The study included 209 consecutive patients who underwent robotic resections for thoracic malignancies between December 2018 and March 2023. Of these, 175 were lung cancer cases, which included 6 pneumonectomies, 125 lobectomies, 34 segmental resections, and 10 wedge resections. The mean in-hospital stay was 3.9 days, with chest tube removal occurring at a mean of 2.4 days. Only 1.7% of cases were converted to an open approach. Complications occurred in 18.7% of cases, including pneumonia, arrhythmia, subcutaneous emphysema, quilothorax, acute lung injury, and ischemic stroke. The overall 30-day mortality rate was 1.1%. The mean number of harvested lymph nodes was twenty-two. Positive pleural lavage was observed in 4% of cases. The outcomes of robotic resections were similar to the previous experience with VATS resections, but with a tendency towards shorter length of stay, earlier chest tube removal, lower rates of complications, and lower mortality. The study concludes that robotic lung resection is a safe procedure with several advantages over VATS resection.
Asset Subtitle
Daniel Brandao
Meta Tag
Speaker
Daniel Brandao
Topic
Early-Stage NSCLC: Limited Resections & Minimally Invasive Approaches
Keywords
robotic lung cancer program
minimally invasive surgery
lung cancer surgery
robotic surgery
viewing
ergonomics
accurate resections
thoracic malignancies
pneumonectomies
lobectomies
×
Please select your language
1
English
5
普通话
11
Dutch